Herbal medicinal products as a future growth opportunity
In addition, Austria offers an optimal environment from a phytomedical perspective, according to CEO and Bionorica owner Michael A. Popp. In 2005, Bionorica founded Bionorica Research GmbH in Innsbruck, a fully owned subsidiary. Since 2012, the phytomedicine producer is the exclusive partner of the Austrian Drug Screening Institute (ADSI). It is the world’s first research institute in which the scientific and business communities targetedly search for medically effective substances in nature.
“A great deal of know-how is required in order to derive highly effective medical agents from plants. Austria boasts a long tradition in phytomedicine, and carries out research at the highest level in this sector. In recent years, it has emerged as a ‘Silicon Valley’ of phytomedicine“, he explained.